|
End-of-day quote
New Zealand S.E.
21/08/2026
|
5-day change | 1st Jan Change | ||
| 4.420 NZD | +0.45% |
|
-0.23% | +30.77% |
| 07-31 | AFT Pharmaceuticals Limited - Shareholder/Analyst Call | |
| 07-31 | New Zealand Shares Fall; AFT Pharmaceuticals Chair to Retire | MT |
| Market Cap | 464M 277M 237M 222M 203M 381M 26.49B 386M 2.62B 1.02B 13.31B 1.04B 1.02B 44.02B | P/E 2027 * |
23.5x | P/E 2028 * | 18.7x |
|---|---|---|---|---|---|
| Enterprise Value | 493M 295M 252M 236M 216M 406M 28.2B 411M 2.79B 1.09B 14.17B 1.11B 1.08B 46.85B | EV / Sales 2027 * |
1.62x | EV / Sales 2028 * | 1.41x |
| Free-Float |
22.37% | Yield 2027 * |
0.74% | Yield 2028 * | 0.94% |
Last Transcript: AFT Pharmaceuticals Limited
| 20/01/24 | Rentevrees zet Bel20 onder druk | |
| 19/01/24 | KBC uitblinker op groene beurs | |
| 19/01/24 | Brusselse beurs opent flink hoger | |
| 19/01/24 | Brussel start handelsdag vermoedelijk in het groen | |
| 19/01/24 | Hyloris gaat samenwerken met AFT Pharmaceuticals |
| 1 day | +0.45% | ||
| 1 week | -0.23% | ||
| Current month | -8.11% | ||
| 1 month | +12.47% | ||
| 3 months | +25.21% | ||
| 6 months | +21.10% | ||
| Current year | +30.77% |
| 1 week | 4.23 |  | 4.45 |
| 1 month | 3.95 | | 4.85 |
| Current year | 3.35 | | 4.85 |
| 1 year | 2.56 | | 4.85 |
| 3 years | 2.37 | | 4.85 |
| 5 years | 2.37 | | 5 |
| 10 years | 1.7 | | 5.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marree Atkinson
HRO | Human Resources Officer | - | 04/09/2012 |
Hartley Atkinson
CEO | Chief Executive Officer | - | 04/09/1997 |
Stuart Houliston
DFI | Director of Finance/CFO | - | 15/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
David Flacks
CHM | Chairman | - | 22/06/2015 |
Hartley Atkinson
BRD | Director/Board Member | - | 04/09/1997 |
Marree Atkinson
BRD | Director/Board Member | - | 04/09/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/7/25 | Buy | Founder | 200,000 | 0.1907% | ||
| 26/6/25 | Free | Founder | 17,755 | 0.0169% | ||
| 2/12/24 | Buy | Founder | 45 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.45% | -0.23% | +70.00% | +28.12% | 275M | |
| +1.20% | +6.81% | +77.58% | +129.16% | 1,109B | |
| +1.52% | +4.24% | +51.67% | +62.16% | 644B | |
| +1.51% | +6.57% | +26.89% | +77.04% | 463B | |
| +1.02% | +5.77% | +43.09% | +47.70% | 371B | |
| +0.85% | +4.07% | +23.88% | +41.58% | 301B | |
| +1.26% | +6.81% | +1.59% | +14.67% | 256B | |
| +1.65% | +5.39% | +47.95% | +67.84% | 234B | |
| +1.59% | +2.09% | -15.52% | -52.29% | 205B | |
| +2.17% | +5.77% | +26.00% | +92.70% | 178B | |
| Average | +1.31% | +2.98% | +35.31% | +50.87% | 376.13B | |
| Weighted average by Cap. | +1.32% | +3.26% | +44.69% | +73.01% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 304M 181M 155M 145M 133M 250M 17.36B 253M 1.72B 670M 8.72B 681M 667M 28.85B | 345M 206M 177M 165M 151M 284M 19.73B 288M 1.95B 762M 9.91B 774M 758M 32.79B |
| Net income | 19.7M 11.76M 10.08M 9.43M 8.63M 16.2M 1.13B 16.41M 111M 43.44M 565M 44.18M 43.21M 1.87B | 24.81M 14.82M 12.7M 11.88M 10.87M 20.41M 1.42B 20.68M 140M 54.73M 712M 55.65M 54.44M 2.36B |
| Net Debt | 29.84M 17.82M 15.27M 14.28M 13.08M 24.54M 1.71B 24.86M 169M 65.81M 857M 66.92M 65.46M 2.83B | 24.6M 14.69M 12.59M 11.78M 10.78M 20.23M 1.41B 20.5M 139M 54.26M 706M 55.17M 53.97M 2.34B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | NZ$4.420 | +0.45% | 7,998 |
| 20/08/26 | NZ$4.400 | +0.23% | 52,370 |
| 19/08/26 | NZ$4.390 | +3.29% | 139,745 |
| 18/08/26 | NZ$4.250 | -1.16% | 27,527 |
| 17/08/26 | NZ$4.300 | -2.27% | 8,824 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AFT Stock
Select your edition
All financial news and data tailored to specific country editions
